Index RUT
P/E -
EPS (ttm) -2.27
Insider Own 1.44%
Shs Outstand 63.57M
Perf Week 19.38%
Market Cap 785.38M
Forward P/E -
EPS next Y -0.07
Insider Trans -3.38%
Shs Float 63.03M
Perf Month 20.55%
Income -144.16M
PEG -
EPS next Q -0.12
Inst Own 107.12%
Short Float 20.93%
Perf Quarter 15.77%
Sales 142.36M
P/S 5.52
EPS this Y 86.77%
Inst Trans 11.18%
Short Ratio 10.40
Perf Half Y 41.41%
Book/sh 0.92
P/B 13.34
EPS next Y 76.27%
ROA -37.08%
Short Interest 13.19M
Perf Year 122.91%
Cash/sh 0.57
P/C 21.35
EPS next 5Y 15.00%
ROE -115.84%
52W Range 4.07 - 12.48
Perf YTD 88.62%
Dividend Est. -
P/FCF -
EPS past 5Y -66.86%
ROI -54.77%
52W High -1.76%
Beta 1.44
Dividend TTM -
Quick Ratio 1.05
Sales past 5Y 23.05%
Gross Margin 6.27%
52W Low 201.19%
ATR (14) 0.50
Dividend Ex-Date -
Current Ratio 1.46
EPS Y/Y TTM -4052.47%
Oper. Margin -13.33%
RSI (14) 74.09
Volatility 3.18% 3.57%
Employees 371
Debt/Eq 3.54
Sales Y/Y TTM -5.28%
Profit Margin -101.27%
Recom 2.20
Target Price 12.75
Option/Short Yes / Yes
LT Debt/Eq 3.49
EPS Q/Q -157.40%
Payout -
Rel Volume 4.12
Prev Close 12.24
Sales Surprise -1.44%
EPS Surprise -63.64%
Sales Q/Q 6.49%
Earnings Sep 09 AMC
Avg Volume 1.27M
Price 12.26
SMA20 17.34%
SMA50 15.91%
SMA200 41.00%
Trades
Volume 5,233,098
Change 0.16%
Date
Action
Analyst
Rating Change
Price Target Change
Sep-28-23 Initiated
William Blair
Mkt Perform
Mar-14-23 Upgrade
KeyBanc Capital Markets
Sector Weight → Overweight
$20
Dec-08-21 Downgrade
KeyBanc Capital Markets
Overweight → Sector Weight
Mar-17-21 Initiated
RBC Capital Mkts
Outperform
$21
Nov-10-20 Initiated
KeyBanc Capital Markets
Overweight
$12
Dec-10-19 Upgrade
First Analysis Sec
Outperform → Strong Buy
Oct-17-19 Initiated
Stephens
Overweight
$8
Oct-16-19 Initiated
Craig Hallum
Buy
$11
Jun-28-19 Upgrade
Janney
Neutral → Buy
$10
May-09-19 Downgrade
Janney
Buy → Neutral
Nov-08-24 06:37AM
Nov-07-24 06:59AM
(Pharmaceutical Technology) +11.48%
Nov-06-24 06:44PM
(The Wall Street Journal)
06:04PM
Oct-17-24 03:03PM
04:05PM
Loading…
Sep-12-24 04:05PM
Sep-10-24 06:59AM
(Thomson Reuters StreetEvents) +17.21%
Sep-09-24 04:19PM
(Associated Press Finance)
04:05PM
Sep-06-24 09:01AM
Sep-05-24 12:02AM
Sep-03-24 04:05PM
(GlobeNewswire) -7.69%
-5.04%
Sep-02-24 05:22PM
Jul-26-24 01:37AM
Jul-03-24 08:02AM
08:53PM
Loading…
Jul-02-24 08:53PM
04:05PM
Jul-01-24 07:00AM
Jun-11-24 01:13PM
May-23-24 08:05AM
May-08-24 12:26PM
May-07-24 04:05PM
May-03-24 04:17AM
03:31AM
02:44AM
Apr-30-24 06:48AM
(Thomson Reuters StreetEvents)
03:05AM
Apr-25-24 02:46PM
Apr-24-24 10:52PM
05:39PM
(Associated Press Finance)
05:25PM
Loading…
05:25PM
Apr-10-24 12:46PM
Apr-01-24 03:07PM
Mar-28-24 12:51PM
Mar-21-24 02:27PM
Mar-20-24 07:00AM
Mar-14-24 12:30PM
Mar-11-24 07:08PM
Mar-10-24 09:01PM
Mar-07-24 02:59PM
09:05AM
Mar-06-24 11:58PM
04:32PM
04:31PM
Jan-30-24 01:11AM
Dec-19-23 05:01AM
Dec-08-23 09:35AM
08:15AM
Dec-07-23 09:54PM
05:51PM
05:40PM
04:42PM
(Associated Press Finance)
04:05PM
Dec-01-23 06:16PM
Nov-30-23 04:05PM
Nov-28-23 09:35AM
Nov-15-23 04:02AM
Nov-08-23 08:05AM
Oct-24-23 07:43AM
Oct-17-23 08:05AM
Sep-26-23 04:05PM
Sep-23-23 01:01AM
Sep-08-23 08:27AM
05:47AM
(Thomson Reuters StreetEvents)
Sep-07-23 05:40PM
04:28PM
(Associated Press Finance)
04:05PM
Aug-31-23 04:05PM
Aug-22-23 08:14AM
Jul-31-23 05:14AM
Jul-03-23 06:50AM
Jun-23-23 10:05AM
Jun-22-23 03:36PM
12:10PM
06:03AM
(Thomson Reuters StreetEvents)
02:55AM
Jun-21-23 08:00PM
04:18PM
04:07PM
Jun-14-23 04:05PM
Jun-08-23 07:37AM
07:30AM
Jun-04-23 08:03AM
May-30-23 05:48PM
May-22-23 03:15AM
May-10-23 04:05PM
May-08-23 06:12AM
Apr-26-23 08:00PM
Apr-24-23 03:41PM
(Investor's Business Daily)
Apr-17-23 08:17AM
Apr-12-23 07:07AM
Apr-04-23 08:05AM
Mar-14-23 12:35PM
11:20AM
07:22AM
06:07AM
(Thomson Reuters StreetEvents)
Mar-13-23 05:55PM
04:05PM
Mar-10-23 07:24AM
Mar-06-23 04:05PM
Avid Bioservices, Inc. engages in clinical and commercial manufacturing of biologics. It focuses on the biopharmaceutical products derived from mammalian cell culture for culture for biotechnology and pharmaceutical companies. It specializes in clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory submissions and support. The company was founded on June 3, 1981 and is headquartered in Tustin, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Kwietniak Matthew R. Chief Commercial Officer Oct 14 '24 Sale 10.15 119 1,208 25,407 Oct 15 07:40 PM Richieri Richard A. Chief Operations Officer Oct 10 '24 Sale 10.05 2,031 20,412 37,704 Oct 11 07:38 PM Richieri Richard A. Chief Operations Officer Oct 10 '24 Sale 10.05 201 2,020 7,218 Oct 11 07:38 PM Kwietniak Matthew R. Chief Commercial Officer Oct 10 '24 Sale 10.05 982 9,869 25,191 Oct 11 07:38 PM Green Nicholas Stewart President & CEO Oct 10 '24 Sale 10.05 17,173 172,589 226,653 Oct 11 07:37 PM Richard A. Richieri Officer Oct 10 '24 Proposed Sale 10.05 2,232 22,430 Oct 10 08:22 PM Nicholas S. Green Officer Oct 10 '24 Proposed Sale 10.05 17,173 172,580 Oct 10 08:21 PM Richieri Richard A. Chief Operations Officer Jul 15 '24 Sale 8.36 530 4,431 34,229 Jul 16 07:50 PM Kwietniak Matthew R. Chief Commercial Officer Jul 15 '24 Sale 8.36 307 2,567 23,410 Jul 16 07:48 PM Kwietniak Matthew R. Chief Commercial Officer Jul 12 '24 Sale 8.05 119 958 22,836 Jul 15 04:40 PM Richieri Richard A. Chief Operations Officer Jul 11 '24 Sale 7.54 1,456 10,978 33,290 Jul 12 04:30 PM Richieri Richard A. Chief Operations Officer Jul 11 '24 Sale 7.54 59 445 6,957 Jul 12 04:30 PM Richieri Richard A. Chief Operations Officer Jul 10 '24 Sale 7.54 910 6,861 30,699 Jul 11 05:02 PM Richieri Richard A. Chief Operations Officer Jul 10 '24 Sale 7.54 115 867 6,881 Jul 11 05:02 PM Kwietniak Matthew R. Chief Commercial Officer Jul 10 '24 Sale 7.54 444 3,348 22,620 Jul 11 05:01 PM Green Nicholas Stewart President & CEO Jul 10 '24 Sale 7.54 7,657 57,734 212,314 Jul 11 05:00 PM Ziebell Mark R V. P., General Counsel Apr 30 '24 Sale 7.40 1,643 12,157 64,834 May 02 08:21 PM Richieri Richard A. Chief Operations Officer Apr 30 '24 Sale 7.40 1,005 7,436 27,132 May 02 08:21 PM Richieri Richard A. Chief Operations Officer Apr 30 '24 Sale 7.40 109 807 5,353 May 02 08:21 PM Kwietniak Matthew R. Chief Commercial Officer Apr 30 '24 Sale 7.40 1,233 9,122 21,797 May 02 08:20 PM Hart Daniel R Chief Financial Officer Apr 30 '24 Sale 7.40 2,826 20,910 82,221 May 02 08:20 PM Green Nicholas Stewart President & CEO Apr 30 '24 Sale 7.40 11,762 87,028 203,606 May 02 08:20 PM Kwietniak Matthew R. Chief Commercial Officer Jan 12 '24 Sale 6.77 274 1,855 19,829 Jan 12 07:34 PM Ziebell Mark R V. P., General Counsel Jan 10 '24 Sale 6.17 1,346 8,305 63,269 Jan 11 07:39 PM Richieri Richard A. Chief Operations Officer Jan 10 '24 Sale 6.17 1,055 6,509 25,625 Jan 11 07:38 PM Richieri Richard A. Chief Operations Officer Jan 10 '24 Sale 6.17 116 716 5,208 Jan 11 07:38 PM Kwietniak Matthew R. Chief Commercial Officer Jan 10 '24 Sale 6.17 1,060 6,540 19,434 Jan 11 07:37 PM Hart Daniel R Chief Financial Officer Jan 10 '24 Sale 6.17 2,408 14,857 79,305 Jan 11 07:36 PM Hancock Richard B Director Dec 13 '23 Buy 5.21 38,803 202,036 117,563 Jan 10 07:56 PM Hancock Richard B Director Dec 15 '23 Buy 5.86 23,000 134,734 78,760 Dec 18 07:31 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite